Key takeaway clinical messages Individuals currently using a GLP-1RA for weight reduction demonstrated suboptimal dietary quality with low intake across adequacy components of the HEI including total and whole fruits, total vegetables and greens and beans, whole grains, seafood and plant proteins, dairy and fatty acids with excess intake of moderation components of the HEI including saturated fat, refined grains, sodium, and fatty acids among individuals currently using a GLP-1RA
Yes, and combination is increasingly standard for people with high cardiovascular or renal risk
Troubleshooting injection site issues that stall weight loss Weight loss stalls happen
Before starting GLP-1 therapy, the team completes medical clearance and baseline labs
Oral berberine capsules delivering 1,000+ mg per day (the dose with actual published data) cost $10 to $15 per month
The results further supported the cardiorenal benefits of GLP-1 medicines with or without concomitant use of sodium-glucose co-transporter 2 inhibitors (SGLT2i)